Cargando…
Exploiting an early immunological window of opportunity in COVID-19
Autor principal: | Russell, Clark D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159187/ https://www.ncbi.nlm.nih.gov/pubmed/34051878 http://dx.doi.org/10.1016/S2213-2600(21)00225-3 |
Ejemplares similares
-
COVID-19 and systemic anticancer therapy: exploiting uncertainty
por: Gelderblom, Hans, et al.
Publicado: (2021) -
Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
por: Verschoor, Chris P, et al.
Publicado: (2022) -
COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023) -
The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
por: Aquino, Erika Neves, et al.
Publicado: (2023) -
Challenges and opportunities to end tuberculosis in the COVID-19 era
por: Wingfield, Tom, et al.
Publicado: (2021)